Skip to content
Search

Latest Stories

Half a million more at risk of type 2 diabetes in England in one year

Half a million more at risk of type 2 diabetes in England in one year

There was an almost 25 per cent increase in the number of individuals under the age of 40 at risk of type 2 diabetes

The number of people in England identified as at risk for type 2 diabetes mellitus (T2DM) has increased by over half a million within a year, according to NHS figures.


Data released by the National Diabetes Audit on June 12 showed that 3.6 million people registered with a GP were found to have non-diabetic hyperglycaemia (also known as pre-diabetes) in 2023, compared with 3.1 million people in 2022 — a notable 18 per cent increase or nearly 550,000 people.

Among those under 40 years old, the figures showed an increase of almost 25 per cent from 173,166 in 2022 to 216,440 in 2023.

People with non-diabetic hyperglycaemia have higher-than-normal blood sugar levels, and they are at greater risk for developing type 2 diabetes and cardiovascular diseases. Typically, this condition is detected through routine blood tests at GP surgeries.

Amanda Pritchard, NHS chief executive, expressed deep concern over the figures, emphasising that type 2 diabetes is not only linked to kidney failure, amputation, heart attack, stroke, and many of the common types of cancer, but it also adds pressure to NHS services.

She assured that the NHS will continue to develop services that support people at risk of developing type 2 diabetes to lead healthier lives.

The NHS has introduced a range of innovative services to prevent people from developing type 2 diabetes and to reduce obesity rates, including the world-leading Healthier You NHS Diabetes Prevention Programme.

More than 1.6 million people have been offered support through the nine-month programme, which provides personalised support with practical tools and advice on healthy eating and lifestyle, increasing physical activity and weight management.

Dr. Clare Hambling, National Clinical Director of Diabetes and Obesity at NHS England, highlighted that the prevalence of type 2 diabetes among individuals under 40 is increasing worldwide, including in England.

According to the NHS, around nine out of 10 people in England living with diabetes have type 2.

The NHS England-funded Type 2 Diabetes and the Young (T2DAY) initiative ensures that people living with early-onset type 2 diabetes receive all recommended diabetes health checks, personalised support tailored to their needs, and evidence-based management to stay well and avoid complications.

It includes additional clinical reviews for those aged 18 to 39 years old living with type 2 diabetes.

The ambitious programme, now entering its second year, is believed to be the world-first targeted support for these high-risk people living with diabetes.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less